Corporate
Description
  • Value proposition

    New ways to care

    Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.

    This makes Pierre Fabre Group :
    💊 A pharmaceutical group with a strong positioning : medical and natural
    🥈 The second largest dermo-cosmetics laboratory in the world
    🥈 The second largest private French pharmaceutical group
    🥇 The market leader in France for products sold over the counter in pharmacies.

    Our portfolio includes several medical franchises and international brands including ;
    Pharmaceutical Care
    Pierre Fabre Oncologie
    Pierre Fabre Dermatologie
    Naturactive
    Eau Thermale Avène
    Klorane
    Ducray
    René Furterer
    A-Derma
    Pierre Fabre Oral Care
    Glytone (US)
    Darrow (Brasil)

    Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.

    Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.

    Pierre Fabre Group has a unique company structure.
    86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.

    In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.

    From Health to Beauty, Family Health, Dermo-Cosmetics, Pharmaceuticals, De la Santé à la Beauté, Dermo-Cosmétique, Médicaments, Santé Familiale, oncology, skincare, haircare, and personal care

  • Original language

    New Ways To Care

    Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale Avène Klorane Ducray René Furterer A-Derma Pierre Fabre Oral Care Glytone (US) Darrow (Brasil) Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.

Entity interactions BETA
Entity TypeTweets Articles
Havas Media Network Havas Media Network
Advertising Services
Other

22 Apr 2022


Société d'Encouragement pour l'Industrie Nationale Société d'Encouragement pour l'Industrie Nationale
industry 4.0, energytech, Civic and Social Organizations
Other

19 Jun 2022


Tour du Valat Tour du Valat
Think Tanks, deeptech
Other

2 Feb 2022


Foundation For Rare Diseases Foundation For Rare Diseases
deeptech, Research Services
Other

31 May 2022


Mediaplus France Mediaplus France
Marketing and Advertising
Other

20 Jun 2022


Radars
Loading...